Therefore, the present investigation was to estimate whether BA treatment possessed the antidepressant-like effects on CUMS induced depression by inhibiting inflammation through down-regulation of HMGB1/TLR4/NF-κB signaling pathway. Here, NFKB1 is linked to depressive symptom measurement.